141,164 members

Skip to content. | Skip to navigation

News

NICE to address issues in treating difficult to control epilepsies

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NICE to address issues in treating difficult to control epilepsies

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating two types of severe treatment-resistant epilepsy.